- FGF-23 is a biomarker of RV dysfunction and congestion in patients with HFrEF2023 | First Faculty of Medicine
- 20 years of nephrologist's journey into the depths of phosphorus toxicity2020 | Faculty of Medicine in Hradec Králové
- Bone disesase in end-stage kidney disease - renal and non-renal components +12021 | Faculty of Medicine in Hradec Králové
- Harmonization of bone marker measurements. Analytical minireview2017 | Publication without faculty affiliation
- New findings in disorder of calcium and phosphate metabolism disorder in renal failure: clinical significance and relation to pharmacotherapy +12006 | Faculty of Medicine in Hradec Králové
- New findings in disorder of calcium and phosphate metabolism disorder in renal failure: clinical significance and relation to pharmacotherapy2006 | First Faculty of Medicine
- Renal bone disease - new findings about its pathogenesis2015 | Publication without faculty affiliation
- Biochemical assessment of bone metabolism disturbances in end-stage renal disease review and clinical implication +12008 | Faculty of Medicine in Hradec Králové
- Biochemical assessment of bone metabolism disturbances in end-stage renal disease review and clinical implication2008 | First Faculty of Medicine
- Fibroblastový růstový faktor 23 (FGF 23) - nově dostupné laboratorní vyšetření s klinickou aplikací2018 | First Faculty of Medicine
- Burosumab in the treatment of X-linked hypophosphatemia in two siblings - a case report2022 | Faculty of Medicine in Hradec Králové, Faculty of Pharmacy in Hradec Králové
- It won't work the usual way - first steps with the new treatment of X-linked hypophosphatemia2021 | Second Faculty of Medicine
- Hyperphosphatemia2017 | First Faculty of Medicine
- Hladiny osteoprotegerinu, solubilního RANKL, fibroblastového růstového faktoru 23, sklerostinu, vitaminu D a osteokalcinu u pacientů s chronickým onemocněním ledvin: výsledky retrospektivní pilotní studiePublication without faculty affiliation
- Association of Fibroblast Growth Factor-23 Levels and Angiotensin-Converting Enzyme Inhibition in Chronic Systolic Heart Failure2015 | Faculty of Physical Education and Sport, Third Faculty of Medicine
- Fibroblast Growth Factor 23 and Matrix-Metalloproteinases in Patients with Chronic Kidney Disease: Are They Associated with Cardiovascular Disease?2009 | Faculty of Medicine in Hradec Králové, First Faculty of Medicine
- Normal 25-Hydroxyvitamin D Levels Are Associated with Less Proteinuria and Attenuate Renal Failure Progression in Children with CKD2016 | Second Faculty of Medicine
- The importance of serum osteopontin and stanniocalcin-1 in renal cell carcinoma2018 | First Faculty of Medicine
- Tumor induced osteomalacia - A long way toward correct diagnosis and management2022 | First Faculty of Medicine, Faculty of Medicine in Pilsen
- Markers of Bone Metabolism Are Affected by Renal Function and Growth Hormone Therapy in Children with Chronic Kidney Disease2015 | Second Faculty of Medicine
